Uveitis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
== Overview ==
== Overview ==
== Epidemiology and Demographics ==
== Epidemiology and Demographics ==
==Prevalence==
Worldwide, the prevalence of uveitis ranges from a low of 69 per 100,000 persons to a high of 204 per 100,000 persons with an average prevalence of 115 per 100,000.
===Prevalence by Subtype===
Several studies have reported prevalence data among a large group of uveitis patients, as follows:
'''By Anatomy'''
* 52-90% have anterior uveitis
* 5-21% have posterior uveitis
* 1-16% have panuveitis
* 1-12% have intermediate uveitis
'''By clinical features'''
* 58% had chronic uveitis
* 78% had non-granulomatous inflammation
* 83% had a non-infectious etiology
==Incidence==
Worldwide, the incidence of uveitis ranges from 17 to 52 per 100,000 per year.
==Age==
The mean age of diagnosis of uveitis is 37 years. The prevalence varies greatly depending on the underlying etiology. The following is an example of age distribution by underlying etiology:
Children: juvenile rheumatoid arthritis, toxocariasis.
Young adults: Behçet's disease, human leukocyte-associated antigen B27-associated uveitis, Fuch's uveitis.
Older adults: Vogt-Koyanagi-Harada (VKH) syndrome, herpes zoster ophthalmicus and, in the developing world, tuberculosis and leprosy.
==Gender==
==Race==
== References ==
== References ==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 21:24, 28 July 2016

Uveitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Uveitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Uveitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Uveitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Uveitis epidemiology and demographics

CDC on Uveitis epidemiology and demographics

Uveitis epidemiology and demographics in the news

Blogs on Uveitis epidemiology and demographics

Directions to Hospitals Treating Uveitis

Risk calculators and risk factors for Uveitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tarek Nafee, M.D. [2]

Overview

Epidemiology and Demographics

Prevalence

Worldwide, the prevalence of uveitis ranges from a low of 69 per 100,000 persons to a high of 204 per 100,000 persons with an average prevalence of 115 per 100,000.

Prevalence by Subtype

Several studies have reported prevalence data among a large group of uveitis patients, as follows: By Anatomy

  • 52-90% have anterior uveitis
  • 5-21% have posterior uveitis
  • 1-16% have panuveitis
  • 1-12% have intermediate uveitis

By clinical features

  • 58% had chronic uveitis
  • 78% had non-granulomatous inflammation
  • 83% had a non-infectious etiology

Incidence

Worldwide, the incidence of uveitis ranges from 17 to 52 per 100,000 per year.

Age

The mean age of diagnosis of uveitis is 37 years. The prevalence varies greatly depending on the underlying etiology. The following is an example of age distribution by underlying etiology: Children: juvenile rheumatoid arthritis, toxocariasis. Young adults: Behçet's disease, human leukocyte-associated antigen B27-associated uveitis, Fuch's uveitis. Older adults: Vogt-Koyanagi-Harada (VKH) syndrome, herpes zoster ophthalmicus and, in the developing world, tuberculosis and leprosy.

Gender

Race

References

Template:WH Template:WS